VPS35 and Parkinson disease: Collectively, these data suggest a rather limited interaction between α-synuclein and VPS35 in neurodegenerative models of PD, but it remains possible that both proteins may indirectly converge on a common pathophysiological pathway such as lysosomal degradation.